Literature DB >> 26734879

Syndrome in question.

Priscila Regina Orso Rebellato1, Camila Makino Rezende1, Eveline Roesler Battaglin1, Brunno Zeni de Lima1, Jose Fillus Neto1.   

Abstract

Morbihan Syndrome is a rare entity with unknown etiology. It is clinically characterized by chronic erythematous edema on the face - especially in the middle and upper third of the face - and creates abnormal facial contours that are initially intermitent but become permanent with the development of the syndrome. The histopathology is nonspecific and its therapy is a major challenge due to poor response to the various treatment options. We present the case of a male patient with a five-month-history of disease.

Entities:  

Mesh:

Year:  2015        PMID: 26734879      PMCID: PMC4689086          DOI: 10.1590/abd1806-4841.20153818

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  2 in total

1.  Successful Long-term Use of Oral Isotretinoin for the Management of Morbihan Disease: A Case Series Report and Review of the Literature.

Authors:  Lauren A Smith; David E Cohen
Journal:  Arch Dermatol       Date:  2012-12

2.  Morbihan syndrome.

Authors:  Stefano Veraldi; Maria Chiara Persico; Claudia Francia
Journal:  Indian Dermatol Online J       Date:  2013-04
  2 in total
  1 in total

Review 1.  Efficacy of long-term intralesional triamcinolone in Morbihan's disease and its possible association with mast cell infiltration.

Authors:  Aikaterini Tsiogka; Josef Koller
Journal:  Dermatol Ther       Date:  2018-04-23       Impact factor: 2.851

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.